Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study-Reference-Cited by-同舟云学术

Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study

Published:2017-06-29 Issue:57 Volume:8 Page:97613-97622
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zheng Lin¹,Guo Chen-Yang¹,Chen Cheng-Shi¹,Xiao Jin-Cheng¹,Hu Hong-Tao¹,Cheng Hong-Tao¹,Zong Deng-Wei¹,Jiang Li¹,Li Hai-Liang¹

Affiliation:

1. Department of Radiology, Zhengzhou University Affiliated Cancer Hospital, Zhengzhou 450008, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility;International Journal of Molecular Sciences;2023-07-17

2. Effects of TACE combined with sorafenib on survival of patients with hepatocellular carcinoma based on ALBI grades and tumor load layers And Establishment of prognosis prediction model;2022-09-15

3. Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta‑analysis;Oncology Letters;2022-08-31

4. The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma;Contrast Media & Molecular Imaging;2022-06-06

5. Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma;Molecular Oncology;2022-01-10